Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 190
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02757651 | KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response | ||
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC | ||
| NCT03574454 | Machine Learning in Myeloma Response | ||
| NCT02978014 | A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy | ||
| NCT03466944 | PUMA (Paediatric Osseous Marrow Assessment) | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer | ||
| NCT00077090 | Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer | ||
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT01006564 | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | ||
| NCT00031850 | Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT02753569 | Imaging NSCLC Treatment Response to Immunotherapy | ||
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer | ||
| NCT03727698 | Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment | ||
| NCT03621332 | HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy. | ||
| NCT04686188 | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer | ||
| NCT04359420 | What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol | ||
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer | ||
| NCT05741801 | Digital Alerts for Sepsis: a Qualitative Study | ||
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | ||
| NCT02305654 | International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | ||
| NCT00028756 | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | ||
| NCT00045045 | Positron Emission Tomography in Detecting Testicle Cancer | ||
| NCT07498829 | Population Based Germline Testing for Early Detection and Prevention of Cancer | ||
| NCT02388308 | Evaluation of Clarity Ultrasound Guidance for Prostate Therapy | ||
| NCT04509986 | GlobalSurg-CovidSurg Week | ||
| NCT03809377 | Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2) | ||
| NCT01124682 | 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | ||
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) | ||
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | ||
| NCT02409212 | Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer | ||
| NCT03934164 | Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT05375591 | AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer | ||
| NCT01000129 | Adaptive Planning in Bladder Cancer | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT02403102 | Imageguided Theranostics in Multiple Myeloma | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT01964677 | MR-HIFU for Bone Metastases | ||
| NCT00199901 | Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma | ||
| NCT04458311 | Abiraterone Acetate in Combination With Tildrakizumab | ||
| NCT02587455 | Pembrolizumab and Palliative Radiotherapy in Lung | ||
| NCT03096093 | Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer | ||
| NCT06636526 | The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). | ||
| NCT00175838 | Primary Thrombocythaemia 1 Trial | ||
| NCT02126800 | Rapid Medical Donation Programme for Breast Cancer | ||
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC) |
